These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 5985776)

  • 1. [Experiences with the endoxan intensive therapy of malignant tumors].
    Gebhardt KH; Becher R
    Med Welt; 1966 Apr; 17():973-6. PubMed ID: 5985776
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of very high cyclophosphamide dosage in 42 patients with solid and lymphoreticular tumors].
    Schubert JC; Ischer M; Hilbert L
    Dtsch Med Wochenschr; 1969 Dec; 94(50):2583-8 passim. PubMed ID: 4187888
    [No Abstract]   [Full Text] [Related]  

  • 3. Intensive cyclophosphamide therapy in advanced malignant disease.
    Binns JH; Southall AC
    Practitioner; 1970 Apr; 204(222):546-8. PubMed ID: 5443539
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hair melanogenesis in endoxan alopecia and its modification by corticosteroids].
    Kostanecki W; Kwiatkowska E; Zborzil J
    Arch Klin Exp Dermatol; 1966 Sep; 226(1):13-20. PubMed ID: 5995016
    [No Abstract]   [Full Text] [Related]  

  • 5. [Shock doses of endoxan in the therapy of malignant lung neoplasms (based on personal observations)].
    Ratajek M
    Wiad Lek; 1970 Jan; 23(1):15-8. PubMed ID: 5412426
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experiences in the use of cyclphosphamide (Endoxan)].
    Aksoycan S; Tauschwitz K
    Med Welt; 1965 Jun; 26():1450-4. PubMed ID: 5318700
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical and animal experimental experiences with intensive Endoxan therapy].
    Nakayama M; Schuster J; Schoyerer W
    Dtsch Med Wochenschr; 1967 Oct; 92(42):1915-9. PubMed ID: 6047906
    [No Abstract]   [Full Text] [Related]  

  • 8. [The results of endoxan application in the therapy of malignant tumors in children].
    Durnov LA; Garin AM; Platinskiĭ LV; Finogenova NA; Shkarenkov VA
    Pediatriia; 1969 May; 48(5):48-51. PubMed ID: 5809920
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effective levels of cyclophosphamide and metabolites in pleural effusions during intravenous therapy (author's transl)].
    Wagner T; Heydrich D
    Arzneimittelforschung; 1982; 32(5):566-8. PubMed ID: 7201835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of advanced breast cancer markedly responding to chemo-endocrine therapy with only slight alopecia].
    Terazaki Y; Nagamatsu H; Ono H; Iwakuma N; Shirouzu K
    Gan To Kagaku Ryoho; 2005 May; 32(5):675-7. PubMed ID: 15918571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nursing management--cancer chemotherapy.
    Lane CG
    J Nurs Care; 1980 Oct; 13(10):7-11. PubMed ID: 6903601
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.
    de Jonge ME; Mathôt RA; Dalesio O; Huitema AD; Rodenhuis S; Beijnen JH
    Bone Marrow Transplant; 2002 Nov; 30(9):593-7. PubMed ID: 12407434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modern chemotherapy of a malignant testicular tumors (author's transl)].
    Arnold H; Fiebig HH
    Radiologe; 1981 Sep; 21(9):421-30. PubMed ID: 6170087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Patterns of serum protein and its fractions under the influence of endoxan treatment].
    Stadnik J; Wodarczyk D; Cieślik R
    Pol Tyg Lek; 1970 Aug; 25(33):1248-50. PubMed ID: 5506778
    [No Abstract]   [Full Text] [Related]  

  • 15. VP-16 and adriamycin in patients with advanced breast cancer.
    Vaughn CB; Maniscalco-Greb E; Lockhard C; Groshko G; Enochs K; Duffin H; Demitrish M
    Am J Clin Oncol; 1982 Oct; 5(5):505-9. PubMed ID: 6897491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy of malignant tumors, vomiting and nausea--what to do?].
    Ell C; König HJ
    Fortschr Med; 1984 Oct; 102(37):913-5. PubMed ID: 6500448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.
    Harper P
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-23-S15-25. PubMed ID: 9346217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of clinical study with epirubicin hydrochloride injectable solution and cyclophosphamide in breast cancer].
    Koyama H; Adachi I; Tajima T; Kanda K; Yoshida M; Miura S; Nakao K; Kikkawa N; Takai S; Toge T; Tamura K; Inaji H; Shiba E
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1721-9. PubMed ID: 9757198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I study on bruceantin administered on a weekly schedule.
    Liesmann J; Belt RJ; Haas CD; Hoogstraten B
    Cancer Treat Rep; 1981; 65(9-10):883-5. PubMed ID: 7273023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience of therapy for sepsis in cancer patients with neutropenia].
    Smirnova AE; Lileev DV
    Anesteziol Reanimatol; 2005; (5):66-7. PubMed ID: 16318058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.